Table 1.
Demographic and clinical characteristics for healthy subjects and psychosis patients.
| Psychosis Patients |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Healthy Subjects | Schizophrenia | Psychotic Bipolar Disorder | ||||||||
| (n=261) | Early (n=127) | Chronic (n=171) | Early (n=51) | Chronic (n=61) | ||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | |||
| Sex (male:female) | 155:106 | 106:21 | 103:68 | 34:17 | 21:40 | |||||
| Race (White:Other) | 183:70 | 87:40 | 101:70 | 36:15 | 50:11 | |||||
| Age | 30.20 | 11.35 | 21.17 | 2.99 | 36.56 | 11.61 | 22.47 | 4.74 | 40.51 | 12.58 |
| Education | 15.12 | 2.18 | 13.29 | 2.07 | 12.88 | 2.80 | 13.48 | 2.03 | 14.64 | 2.33 |
| Parental Education | 14.38 | 2.41 | 14.97 | 2.58 | 13.47 | 3.19 | 15.07 | 2.31 | 14.33 | 3.07 |
| Premorbid IQ | 110.19 | 11.59 | 101.42 | 15.12 | 95.47 | 17.17 | 106.02 | 13.41 | 103.82 | 15.62 |
| PANSS Postive | -- | -- | 17.74 | 7.03 | 20.52 | 7.44 | 17.41 | 9.09 | 14.82 | 7.22 |
| PANSS Negative | -- | -- | 17.85 | 7.84 | 15.31 | 6.86 | 11.61 | 5.94 | 10.40 | 3.03 |
| PANSS General | -- | -- | 33.27 | 8.15 | 33.42 | 8.25 | 27.41 | 7.76 | 26.62 | 6.97 |
| HAMD-17 | -- | -- | 8.56 | 5.73 | 9.72 | 6.78 | 7.48 | 5.64 | 8.89 | 6.54 |
| YMRS | -- | -- | 3.44 | 5.36 | 5.64 | 6.56 | 7.08 | 10.33 | 7.00 | 9.40 |
| Duration of Illness, years | -- | -- | 0.44 | 0.49 | 16.19 | 11.05 | 0.38 | 0.53 | 14.52 | 11.48 |
| Chlorpromazine Equivalent | -- | -- | 318.14 | 162.52 | 550.28 | 403.09 | 336.71 | 266.22 | 341.29 | 199.11 |
Note: Subject education available for 236 healthy subjects, 379 psychosis patients; parental education available for 220 healthy subjects, 349 psychosis patients; duration of illness .available for 405 psychosis patients; PANSS available for 397 psychosis patients; HAMD available for 404; YMRS available for 376 psychosis patients.
Abbreviations: SD=Standard Deviation